Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Biotechnology Animations – Biotechnology Illustrations

Clinical Animations / Trial Animations

Clinical Studies Animated Method of Action Video

Medical Animation Studio produces clinical animations and clinical illustrations.  Custom 3d trail illustrations and clinical illustrations for e learning can also be produced.   Biotechnology animations and biotechnology illustrations created for biotech companies and biotechnology marketing companies.
Biotechnology animated method of action video. 
Dr Nano
Investigation casts doubt over trial used to support top-selling anti-clotting drug
An investigation published by The BMJ today raises new concerns about the top-selling anti-clotting drug, rivaroxaban (Xarelto).
The hidden costs of the financial conflict of interest in medicine
In a paper published in the current issue of Psychotherapy and Psychosomatics, Giovanni A.
Benzodiazepines 'do not increase dementia risk'
Past research has linked benzodiazepines - drugs used to treat anxiety and insomnia - to increased dementia risk for seniors, but a new study has found no such association.
Microreactor replaces animal testing
Researchers all over Europe are working on alternatives to animal testing that can be used to evaluate the adverse side-effects of medications. But many of these test methods still present problems.
Moderate improvements in blood glucose levels could deliver significant benefits for people with diabetes in the UK and the NHS
Sanofi, Diabetes UK and JDRF have announced the publication of IMPACT 2 in the journal Diabetic Medicine.
Royal College of Surgeons backs calls for increase in placebo surgery
A working party looking into the inclusion of placebos in surgical trials has led to a recommendation for greater use of the controversial method by the Royal College of Surgeons of England.
Results from Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure published
Jazz Pharmaceuticals plc has announced that data from the phase 3 pivotal study of defibrotide were published online in BLOOD, the Journal of the American Society of Hematology (ASH).
Myeloma UK and the Structural Genomics Consortium announce open-access collaboration to discover new drug targets for myeloma
Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to discover and characterise novel drug targets for myeloma using structural biology...
Nerve damage in MS could be prevented with epilepsy drug
An epilepsy drug - phenytoin - reduced nerve damage by 30% in people with optic neuritis, a new study found, bringing us closer to a neuroprotective drug for multiple sclerosis.
Improve early access to data from catastrophic clinical trials: A statement on behalf of the British Pharmacological Society
The British Pharmacological Society has published a statement calling for improved early access to data from catastrophic clinical trials, following the French clinical trial.
Loughborough University to help develop new life changing haemophilia A therapy
Loughborough University is working with a team of international partners on a new €5.6 million project to develop a cell based haemophilia A therapy.
Wanted: women without cancer to contribute to Moffitt Cancer Center's quality-of-life research
Moffitt Cancer Center is recruiting women without a history of cancer to participate in a study that will compare common problems, such as fatigue, sleep disruption and inflammation, to women who...
French drug trial details murky, should not influence future cannabinoid research
Contrary to initial reports, the drug tested on paid volunteers in a French study, which resulted in one death and five hospitalizations, did not contain cannabis or cannabinoids.
Profectus Viosciences initiates Ebola vaccine Phase 1 clinical trial
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the...
New findings may enhance PARP inhibitors therapy in breast cancer
Findings from a new study reveal that PARP inhibitors, an emerging class of drugs being studied in cancer clinical trials, may be enhanced by combining them with inhibitors targeting an oncogene...
WindowsFlashQuicktime
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2016
Content Management / Website Design by Tresware